167 related articles for article (PubMed ID: 17988266)
1. Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation.
Coppo R; Amore A; Chiesa M; Lombardo F; Cirina P; Andrulli S; Passerini P; Conti G; Peruzzi L; Giraudi R; Messina M; Segoloni G; Ponticelli C
Clin Transplant; 2007; 21(6):728-37. PubMed ID: 17988266
[TBL] [Abstract][Full Text] [Related]
2. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients.
Masutani K; Miyake K; Nakashima H; Hirano T; Kubo M; Hirakawa M; Tsuruya K; Fukuda K; Kanai H; Otsuka T; Hirakata H; Iida M
Am J Kidney Dis; 2003 Feb; 41(2):371-9. PubMed ID: 12552499
[TBL] [Abstract][Full Text] [Related]
3. IgA-containing immune complexes in the urine of IgA nephropathy patients.
Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
[TBL] [Abstract][Full Text] [Related]
4. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of renin-angiotensin system genes in IgA nephropathy.
Woo KT; Lau YK; Choong LH; Zhao Y; Tan HB; Fook-Chong S; Tan EK; Yap HK; Wong KS
Nephrology (Carlton); 2004 Oct; 9(5):304-9. PubMed ID: 15504143
[TBL] [Abstract][Full Text] [Related]
6. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
[TBL] [Abstract][Full Text] [Related]
7. FcgammaRIIa-131R allele and FcgammaRIIIa-176V/V genotype are risk factors for progression of IgA nephropathy.
Tanaka Y; Suzuki Y; Tsuge T; Kanamaru Y; Horikoshi S; Monteiro RC; Tomino Y
Nephrol Dial Transplant; 2005 Nov; 20(11):2439-45. PubMed ID: 16221721
[TBL] [Abstract][Full Text] [Related]
8. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C
Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
[TBL] [Abstract][Full Text] [Related]
9. CD4-positive cells from patients with IgA nephropathy demonstrate increased mRNA of cytokines that induce the IgA switch and differentiation.
Lai KN; Ho RT; Leung JC; Chui YL; Lim PL; Lui SF; Li PK
J Pathol; 1994 Sep; 174(1):13-22. PubMed ID: 7965399
[TBL] [Abstract][Full Text] [Related]
10. Recurrent mesangial IgA nephritis following renal transplantation.
Odum J; Peh CA; Clarkson AR; Bannister KM; Seymour AE; Gillis D; Thomas AC; Mathew TH; Woodroffe AJ
Nephrol Dial Transplant; 1994; 9(3):309-12. PubMed ID: 8052439
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation.
Namba Y; Oka K; Moriyama T; Ichimaru N; Kyo M; Kokado Y; Ito T; Imai E; Aozasa K; Okuyama A; Takahara S
Transplant Proc; 2004 Jun; 36(5):1314-6. PubMed ID: 15251321
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of IgA nephropathy and Henoch-Schönlein purpura after kidney transplantation: risk factors and graft survival.
Soler MJ; Mir M; Rodriguez E; Orfila A; Munne A; Vázquez S; Lloveras J; Puig JM
Transplant Proc; 2005 Nov; 37(9):3705-9. PubMed ID: 16386512
[TBL] [Abstract][Full Text] [Related]
13. New insights in the pathogenesis of IgA nephropathy.
Monteiro RC
Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
[TBL] [Abstract][Full Text] [Related]
14. [Association of single nucleotide polymorphism of megsin gene with IgA nephropathy].
Wang ZH; Chen N; Pan XX; Ren H; Wang WM; Zhang W; Hao CL; Zhu J; Lu Y; Han B
Zhonghua Yi Xue Za Zhi; 2006 May; 86(19):1337-41. PubMed ID: 16796905
[TBL] [Abstract][Full Text] [Related]
15. Macromolecular IgA and abnormal IgA reactivity in sera from children with IgA nephropathy. Italian Collaborative Paediatric IgA Nephropathy Study.
Coppo R; Amore A; Gianoglio B; Porcellini MG; Peruzzi L; Gusmano R; Giani M; Sereni F; Gianviti A; Rizzoni G
Clin Nephrol; 1995 Jan; 43(1):1-13. PubMed ID: 7697930
[TBL] [Abstract][Full Text] [Related]
16. Role of interferon-gamma gene polymorphisms in susceptibility to IgA nephropathy: a family-based association study.
Schena FP; Cerullo G; Torres DD; Scolari F; Foramitti M; Amoroso A; Pirulli D; Floege J; Mertens PR; Zerres K; Alexopoulos E; Kirmizis D; Zelante L; Bisceglia L
Eur J Hum Genet; 2006 Apr; 14(4):488-96. PubMed ID: 16493441
[TBL] [Abstract][Full Text] [Related]
17. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients.
Itoh A; Iwase H; Takatani T; Nakamura I; Hayashi M; Kobayashi Y; Hiki Y; Okamoto M
J Nephrol; 2005; 18(5):575-81. PubMed ID: 16299684
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism in the Ialpha1 germ-line transcript regulatory region and IgA productivity in patients with IgA nephropathy.
Yano N; Asakura K; Endoh M; Abe Y; Nomoto Y; Sakai H; Kurokawa K; Tsukamoto H
J Immunol; 1998 May; 160(10):4936-42. PubMed ID: 9590241
[TBL] [Abstract][Full Text] [Related]
19. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
van der Boog PJ; van Kooten C; van Seggelen A; Mallat M; Klar-Mohamad N; de Fijter JW; Daha MR
Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
[TBL] [Abstract][Full Text] [Related]
20. Vascular diseases and their risk factors in IgA nephropathy.
Myllymäki J; Syrjänen J; Helin H; Pasternack A; Kattainen A; Mustonen J
Nephrol Dial Transplant; 2006 Jul; 21(7):1876-82. PubMed ID: 16522659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
